Article

A Caregiver's Perspective: Light Chain (AL) Amyloidosis Treatment

Author(s):

Susan Weisman

Susan Weisman, a light chain (AL) amyloidosis caregiver for her husband since 2009, touches on a few of her husband's treatments in an approximate timeline.

Susan Weisman, a light chain (AL) amyloidosis caregiver for her husband since 2009, touches on a few of her husband's treatments in an approximate timeline.

Related Videos
The APAC Recap: Cardiomyopathy at CAPP Live 2024 with Greg Duck, PA-C | Image Credit: APAC
The APAC Recap: Peripheral Artery Disease at CAPP Live 2024 with Bob Ross, PA-C | Image Credit: APAC
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Related Content
A Pillared Approach: A Suite of THerapies for a Spectrum of Metabolic Disease
December 6th 2024

A Pillared Approach: A Suite of Therapies for a Spectrum of Metabolic Disease

Patrick Campbell
Diabetes Dialogue: News and Updates in Diabetes at AHA 2024
November 21st 2024

Diabetes Dialogue: News and Updates in Diabetes at AHA 2024

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
This Year in Medicine 2024: Stories that Defined Healthcare
December 3rd 2024

This Year in Medicine 2024: Stories that Defined Healthcare

HCPLive Editorial Staff
Kidney Compass default thumbnail with podcast logo and headshots of hosts Brendon Neuen and Shikha Wadhwani.
October 28th 2024

Kidney Compass: FLOW Insights from Kidney Week 2024, with Katherine Tuttle, MD

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Obesity Drug MariTide Achieves Up to 20% Weight Loss in Phase 2 Trial | Image Credit: Amgen
November 26th 2024

Obesity Drug MariTide Achieves Up to 20% Weight Loss in Phase 2 Trial

Connor Iapoce
FDA Accepts Alnylam’s sNDA for Vutrisiran for ATTR-CM | Image Credit: US Food and Drug Administration
November 26th 2024

FDA Accepts Alnylam’s sNDA for Vutrisiran for ATTR-CM

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.